BR0114366A - Composto, formulação farmacêutica, uso de um composto, método de profilaxia ou tratamento de uma arritimia e processo para a preparação de um composto - Google Patents
Composto, formulação farmacêutica, uso de um composto, método de profilaxia ou tratamento de uma arritimia e processo para a preparação de um compostoInfo
- Publication number
- BR0114366A BR0114366A BR0114366-2A BR0114366A BR0114366A BR 0114366 A BR0114366 A BR 0114366A BR 0114366 A BR0114366 A BR 0114366A BR 0114366 A BR0114366 A BR 0114366A
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- treatment
- prophylaxis
- pharmaceutical formulation
- arrhythmia
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 7
- 238000000034 method Methods 0.000 title abstract 3
- 238000011282 treatment Methods 0.000 title abstract 3
- 206010003119 arrhythmia Diseases 0.000 title abstract 2
- 230000006793 arrhythmia Effects 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 238000011321 prophylaxis Methods 0.000 title abstract 2
- KZOCHEDMAHPYCK-UHFFFAOYSA-N 4-[3-[3-(3,3-dimethyl-2-oxobutyl)-9-oxa-3,7-diazabicyclo[3.3.1]nonan-7-yl]propylamino]benzonitrile Chemical compound C1C(O2)CN(CC(=O)C(C)(C)C)CC2CN1CCCNC1=CC=C(C#N)C=C1 KZOCHEDMAHPYCK-UHFFFAOYSA-N 0.000 abstract 1
- 206010003130 Arrhythmia supraventricular Diseases 0.000 abstract 1
- 206010047281 Ventricular arrhythmia Diseases 0.000 abstract 1
- 230000001746 atrial effect Effects 0.000 abstract 1
- 150000008107 benzenesulfonic acids Chemical class 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PH12000002701 | 2000-10-02 | ||
| PCT/SE2000/001994 WO2001028992A2 (en) | 1999-10-18 | 2000-10-13 | New oxabispidine compounds useful in the treatment of cardiac arrhythmias |
| PCT/SE2001/002129 WO2002028863A1 (en) | 2000-10-02 | 2001-10-01 | New oxabispidine compound useful in the treatment of cardiac arrhythmias |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0114366A true BR0114366A (pt) | 2003-08-12 |
Family
ID=52573779
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0114366-2A BR0114366A (pt) | 2000-10-02 | 2001-10-01 | Composto, formulação farmacêutica, uso de um composto, método de profilaxia ou tratamento de uma arritimia e processo para a preparação de um composto |
| BR0114367-0A BR0114367A (pt) | 2000-10-02 | 2001-10-01 | Processo para a preparação de um composto, e, composto |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0114367-0A BR0114367A (pt) | 2000-10-02 | 2001-10-01 | Processo para a preparação de um composto, e, composto |
Country Status (22)
| Country | Link |
|---|---|
| US (5) | US6936712B1 (cg-RX-API-DMAC7.html) |
| EP (3) | EP1900741A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2004510775A (cg-RX-API-DMAC7.html) |
| KR (2) | KR20030032060A (cg-RX-API-DMAC7.html) |
| CN (3) | CN1243754C (cg-RX-API-DMAC7.html) |
| AR (1) | AR030756A1 (cg-RX-API-DMAC7.html) |
| AU (3) | AU9250401A (cg-RX-API-DMAC7.html) |
| BR (2) | BR0114366A (cg-RX-API-DMAC7.html) |
| CA (2) | CA2421776A1 (cg-RX-API-DMAC7.html) |
| CZ (1) | CZ294217B6 (cg-RX-API-DMAC7.html) |
| EE (1) | EE200300131A (cg-RX-API-DMAC7.html) |
| HU (1) | HUP0302288A3 (cg-RX-API-DMAC7.html) |
| IL (3) | IL154803A0 (cg-RX-API-DMAC7.html) |
| IS (1) | IS6744A (cg-RX-API-DMAC7.html) |
| MX (2) | MXPA03002759A (cg-RX-API-DMAC7.html) |
| NO (2) | NO20031413L (cg-RX-API-DMAC7.html) |
| NZ (2) | NZ524573A (cg-RX-API-DMAC7.html) |
| PL (1) | PL364047A1 (cg-RX-API-DMAC7.html) |
| RU (1) | RU2003107668A (cg-RX-API-DMAC7.html) |
| SK (1) | SK3862003A3 (cg-RX-API-DMAC7.html) |
| WO (2) | WO2002028864A1 (cg-RX-API-DMAC7.html) |
| ZA (2) | ZA200301757B (cg-RX-API-DMAC7.html) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9903759D0 (sv) * | 1999-10-18 | 1999-10-18 | Astra Ab | Pharmaceutically active compounds |
| GB0223712D0 (en) * | 2002-10-14 | 2002-11-20 | Astrazeneca Ab | Chemical intermediate |
| SE0401539D0 (sv) * | 2004-06-15 | 2004-06-15 | Astrazeneca Ab | New compounds |
| SE0401540D0 (sv) * | 2004-06-15 | 2004-06-15 | Astrazeneca Ab | New compounds |
| CN101243093A (zh) | 2005-06-13 | 2008-08-13 | 阿斯利康(瑞典)有限公司 | 用于治疗心律不齐的新型氧杂双哌啶化合物 |
| WO2006137772A1 (en) * | 2005-06-20 | 2006-12-28 | Astrazeneca Ab | New physical form of n,n´- disubstituted oxabispidines |
| WO2006137770A1 (en) * | 2005-06-20 | 2006-12-28 | Astrazeneca Ab | Process for the preparation of n,n´- disubstituted oxabispidines |
| AR054391A1 (es) * | 2005-06-20 | 2007-06-20 | Astrazeneca Ab | Procedimiento para la preparacion de 3,7- dihidroxi-1,5-diazaciclooctanos |
| BRPI0611841A2 (pt) * | 2005-06-20 | 2016-08-30 | Astrazeneca Ab | processos para isolar um sal, para preparar um sal, e para a preparação de um composto |
| CN103319423B (zh) * | 2013-06-28 | 2015-10-28 | 江苏师范大学 | 一种3,7-双芳基-1,5-二氧-3,7-二氮杂环辛烷的合成方法 |
| KR20150082070A (ko) | 2014-01-06 | 2015-07-15 | (주)신비넷 | 위치 인식 시스템 및 그 시스템에서의 위치 인식을 위한 장치 및 방법 |
| EP3059229A1 (en) | 2015-02-17 | 2016-08-24 | Evonik Degussa GmbH | Method for the epoxidation of an olefin with hydrogen peroxide |
| CN115054728B (zh) * | 2022-07-18 | 2023-11-07 | 中国科学院大学宁波华美医院 | 一种仿生骨组织工程支架材料及其制备方法 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3503939A (en) * | 1967-03-29 | 1970-03-31 | Du Pont | Polyamides from heterocyclic diamines |
| DE2428792A1 (de) * | 1974-06-14 | 1976-01-02 | Knoll Ag | Neue antiarrhythmika |
| DE3112055A1 (de) * | 1981-03-27 | 1982-10-07 | Basf Ag, 6700 Ludwigshafen | Bispidinderivate, ihre herstellung und diese enthaltende arzneimittel |
| DE3234697A1 (de) * | 1982-09-18 | 1984-03-22 | Kali-Chemie Pharma Gmbh, 3000 Hannover | Neue diazabicyclo-(3,3,1)-nonane |
| DE3732094A1 (de) * | 1987-09-24 | 1989-04-06 | Basf Ag | Bispidinderivate als klasse iii-antiarrhythmika |
| DE3902357A1 (de) | 1989-01-27 | 1990-08-02 | Hoechst Ag | Verwendung von rheniumorganischen verbindungen zur oxidation von c-c-mehrfachbindungen, darauf basierende oxidationsverfahren und neue rheniumorganische verbindungen |
| US5140033A (en) * | 1989-04-03 | 1992-08-18 | Bayer Aktiengesellschaft | Antibacterial 5-alkylquinolonecarboxylic acids |
| US5110933A (en) * | 1989-11-13 | 1992-05-05 | Board Of Regents Of Oklahoma State University | Salts of 3-azabicyclo[3.3.1]nonanes as antiarrhythmic agents, and precursors thereof |
| US5468858A (en) * | 1993-10-28 | 1995-11-21 | The Board Of Regents Of Oklahoma State University Physical Sciences | N-alkyl and n-acyl derivatives of 3,7-diazabicyclo-[3.3.1]nonanes and selected salts thereof as multi-class antiarrhythmic agents |
| US5831099A (en) | 1995-03-10 | 1998-11-03 | The United States Of America As Represented By The Secretary Of The Army | Compounds of 1,5-disubstituted-3,7 diaza bicyclo 3.3.0! octanes and products containing the same |
| US5939568A (en) | 1997-01-31 | 1999-08-17 | The Scripps Research Institute | Accelerated catalysis of olefinic epoxidations |
| SE9704709D0 (sv) | 1997-12-17 | 1997-12-17 | Astra Ab | Pharmaceutically active compounds |
| HK1042091A1 (zh) * | 1999-04-09 | 2002-08-02 | 阿斯特拉曾尼卡有限公司 | 金剛烷衍生物 |
| AUPQ274199A0 (en) | 1999-09-09 | 1999-09-30 | Ericsson Australia Pty Ltd | Information transmission rate control across a core network |
| SE9903759D0 (sv) | 1999-10-18 | 1999-10-18 | Astra Ab | Pharmaceutically active compounds |
| GB0223712D0 (en) * | 2002-10-14 | 2002-11-20 | Astrazeneca Ab | Chemical intermediate |
-
2001
- 2001-09-18 AR ARP010104406A patent/AR030756A1/es unknown
- 2001-10-01 AU AU9250401A patent/AU9250401A/xx active Pending
- 2001-10-01 RU RU2003107668/04A patent/RU2003107668A/ru not_active Application Discontinuation
- 2001-10-01 JP JP2002532446A patent/JP2004510775A/ja active Pending
- 2001-10-01 CA CA002421776A patent/CA2421776A1/en not_active Abandoned
- 2001-10-01 AU AU2001292503A patent/AU2001292503A1/en not_active Abandoned
- 2001-10-01 EP EP07121849A patent/EP1900741A1/en not_active Withdrawn
- 2001-10-01 IL IL15480301A patent/IL154803A0/xx active IP Right Grant
- 2001-10-01 US US10/381,900 patent/US6936712B1/en not_active Expired - Fee Related
- 2001-10-01 NZ NZ524573A patent/NZ524573A/en unknown
- 2001-10-01 EE EEP200300131A patent/EE200300131A/xx unknown
- 2001-10-01 MX MXPA03002759A patent/MXPA03002759A/es active IP Right Grant
- 2001-10-01 CN CNB018167225A patent/CN1243754C/zh not_active Expired - Fee Related
- 2001-10-01 EP EP01972865A patent/EP1330461A1/en not_active Withdrawn
- 2001-10-01 WO PCT/SE2001/002130 patent/WO2002028864A1/en not_active Ceased
- 2001-10-01 WO PCT/SE2001/002129 patent/WO2002028863A1/en not_active Ceased
- 2001-10-01 NZ NZ524574A patent/NZ524574A/en unknown
- 2001-10-01 SK SK386-2003A patent/SK3862003A3/sk not_active Application Discontinuation
- 2001-10-01 CN CNA018167217A patent/CN1468244A/zh active Pending
- 2001-10-01 KR KR10-2003-7004638A patent/KR20030032060A/ko not_active Withdrawn
- 2001-10-01 BR BR0114366-2A patent/BR0114366A/pt not_active IP Right Cessation
- 2001-10-01 IL IL15480201A patent/IL154802A0/xx unknown
- 2001-10-01 CA CA002422810A patent/CA2422810A1/en not_active Abandoned
- 2001-10-01 CZ CZ2003923A patent/CZ294217B6/cs not_active IP Right Cessation
- 2001-10-01 HU HU0302288A patent/HUP0302288A3/hu unknown
- 2001-10-01 CN CNA2005100035779A patent/CN1793146A/zh active Pending
- 2001-10-01 BR BR0114367-0A patent/BR0114367A/pt not_active IP Right Cessation
- 2001-10-01 MX MXPA03002679A patent/MXPA03002679A/es not_active Application Discontinuation
- 2001-10-01 PL PL01364047A patent/PL364047A1/xx not_active Application Discontinuation
- 2001-10-01 AU AU2001292504A patent/AU2001292504B2/en not_active Ceased
- 2001-10-01 KR KR1020037004639A patent/KR100812920B1/ko not_active Expired - Fee Related
- 2001-10-01 JP JP2002532447A patent/JP4248873B2/ja not_active Expired - Fee Related
- 2001-10-01 EP EP01972866A patent/EP1330462A1/en not_active Withdrawn
- 2001-10-01 US US10/398,171 patent/US20040039199A1/en not_active Abandoned
-
2003
- 2003-03-03 ZA ZA200301757A patent/ZA200301757B/en unknown
- 2003-03-06 IL IL154803A patent/IL154803A/en not_active IP Right Cessation
- 2003-03-13 IS IS6744A patent/IS6744A/is unknown
- 2003-03-18 ZA ZA200302202A patent/ZA200302202B/en unknown
- 2003-03-27 NO NO20031413A patent/NO20031413L/no not_active Application Discontinuation
- 2003-03-27 NO NO20031414A patent/NO20031414L/no not_active Application Discontinuation
-
2005
- 2005-03-25 US US11/089,325 patent/US7439355B2/en not_active Expired - Fee Related
-
2008
- 2008-09-15 US US12/232,293 patent/US20090036675A1/en not_active Abandoned
-
2009
- 2009-03-06 US US12/382,068 patent/US20090240051A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0114366A (pt) | Composto, formulação farmacêutica, uso de um composto, método de profilaxia ou tratamento de uma arritimia e processo para a preparação de um composto | |
| BR9907270A (pt) | Composto, composição farmacêutica, uso de um composto, e, processos para tratamento ou profilaxia de doenças inflamatórias, por exemplo, asma ou copd, e para a preparação de um composto | |
| BR0208829A (pt) | Sal farmaceuticamente aceitável, composto, processos para a preparação de um sal, de um composto e de uma forma cristalina dos compostos, formulação farmacêutica, uso de um composto, e, método de profilaxia ou tratamento de uma arritmia | |
| BR9905109A (pt) | "compostos farmaceuticamente ativos" | |
| BR9609503A (pt) | Composto, uso de um composto, processo de tratamento de condições onde a inibição de pde especìfico para cgmp é de benefìcio terapêutico, em corpo de animal humano ou não humano, composição farmacêutica, e processos para preparar a mesma e um composto | |
| BR0114321A (pt) | Composto, composição farmacêutica, uso de um composto, método de tratamento ou profilaxia de doenças inflamatórias, e, processo para preparar um composto | |
| CR8117A (es) | Sal de acido fosforico de un inhibidor de la dipeptidil peptidasa-iv | |
| BR0004786A (pt) | Compostos farmaceuticamente ativos | |
| EP0391002A3 (en) | Pharmaceutical compositions containing n-(3,4-dimethoxycinnamoyl) anthranilic acid | |
| BR0213760A (pt) | Composto, composição farmacêutica, uso do composto e método para tratamento de doença ou condição | |
| BR0206935A (pt) | Composto, formulação farmacêutica, uso de um composto, método de tratamento e/ou profilaxia de condições associadas com a inibição da glicogênio sintase quinase-3, e, processo para a preparação de um composto | |
| BR0016678A (pt) | Composto, formulação farmacêutica, uso de um composto, método para profilaxia ou tratamento de uma arritmia, e, processo para preparação de um composto | |
| BR0206791A (pt) | Composto, formulação farmacêutica, uso de um composto, método de profilaxia ou tratamento de uma arritmia, e, processo para a preparação de um composto | |
| ES2042534T3 (es) | Un proceso para la preparacion de una preparacion topica en forma de un hidrogel. | |
| WO2007060108A3 (de) | Aerosolformulierung für die inhalation enthaltend ein anticholinergikum | |
| GR3001300T3 (en) | Phospholipid-containing products, their preparation and use | |
| BRPI0409882A (pt) | compostos, composições farmacêuticas, método para o tratamento ou profilaxia de doenças, e, usos de compostos e de um ou mais compostos em combinação com outros compostos farmacologicamente ativos | |
| WO2007060104A3 (de) | Aerosolformulierung für die inhalation enthaltend ein anticholinergikum | |
| JP2004510775A5 (cg-RX-API-DMAC7.html) | ||
| BR0208830A (pt) | Composição farmacêutica de liberação modificada, processo para a preparação de uma composição, uso de uma composição, e, método de profilaxia ou tratamento de uma arritimia | |
| BR0208828A (pt) | Formulação farmacêutica de liberação imediata, processo para a preparação de uma formulação, composição farmacêutica sólida, processo para a formação de uma composição, uso de uma formulação, e, método de profilaxia ou tratamento de uma arritmia | |
| BR9906869A (pt) | Preparações farmacêuticas seca e aquosa congelada, processos para a manufatura de uma preparação farmacêutica seca e aquosa congelada e para a profilaxia e/ou tratamento de arritmia cardìaca, sal, e, uso de um composto antiarrìtmico de classe iii | |
| BR0112267A (pt) | Composto, formulação farmacêutica, uso de um composto, método de profilaxia ou tratamento de uma arritmia, e, processo para a preparação de um composto | |
| BRPI0512012A (pt) | composto ou um derivado farmaceuticamente aceitável do mesmo, formulação farmacêutica, uso de um composto, método de profilaxia ou tratamento de uma arritmia, e, processo para a preparação de um composto | |
| BR0208884A (pt) | Determinados sais do ácido discodermolido, composições farmacêuticas que contêm os mesmos, e o uso dos mesmos no tratamento de tumores |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5A, 6A E 7A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 1964 DE 26/08/2008 E CONSIDERANDO A AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS. |